Access the complete database of venture-funded biotechnology companies. Discover 5,762 biotech startups working on drug discovery, gene therapy, synthetic biology, and precision medicine, with verified founder contacts and funding data.
Get founder emails, funding data, and company details in one CSV
| Company | Funding |
|---|---|
| $599K | |
| $1.0M | |
| $9.8M | |
| $250.0M | |
| $16.3M | |
| $300K | |
| $638K | |
| $40.0M | |
| $1.5M | |
| $3.0M | |
| $9.5M | |
| $10.0M | |
| $3K | |
| Undisclosed | |
| $645K | |
| $20K | |
| Undisclosed | |
| Undisclosed | |
| $150K | |
| $15.0M | |
| $500K | |
| $40.0M | |
| $400K | |
| $75.0M | |
| $37.2M | |
| $22.0M | |
| $3.3M | |
| $7.4M | |
| $300K | |
| $3.0M | |
| $15.0M | |
| $1.5M | |
| $3.7M | |
| $3.0M | |
| $5.0M | |
| Undisclosed | |
| $500K | |
| $260K | |
| $495K | |
| $495K | |
| $2.6M | |
| $1.5M | |
| $200K | |
| $495K | |
| $14.5M | |
| $3.0B | |
| $484K | |
| $1.5M | |
| $350K | |
| $82.0M | |
| Undisclosed | |
| $667K | |
| Undisclosed | |
| $250K | |
| $10.7M | |
| $30.0M | |
| $2.0M | |
| Undisclosed | |
| Undisclosed | |
| $16.0M | |
| $72K | |
| $191.0M | |
| $325.0M | |
| $972K | |
| $540K | |
| $300K | |
| $2.1M | |
| $90.0M | |
| $5.0M | |
| $6.0M | |
| $30.0M | |
| Undisclosed | |
| $6.6M | |
| $325K | |
| $175.0M | |
| $6.7M | |
| $3.5M | |
| $10.4M | |
| $4.0M | |
| $14.3M | |
| $32.0M | |
| $750K | |
| $35K | |
| $250K | |
| $3.9M | |
| $250K | |
| $57.9M | |
| $988K | |
| $35.0M | |
| $565K | |
| $24.1M | |
| $29.4M | |
| $1.2M | |
| $4.0M | |
| $37.0M | |
| $21.0M | |
| $1.6M | |
| $690K | |
| $1.0M | |
| $6.8M |
Showing 100 of 5,762 companies
View All 5,762 Biotech CompaniesGet verified contact info for decision-makers at 5,762 funded startups
Biotechnology startups are pushing the boundaries of drug discovery, gene therapy, synthetic biology, agricultural biotech, and precision medicine. The biotech sector commands some of the largest venture funding rounds due to the capital-intensive nature of research, clinical trials, and regulatory approvals.
Key biotech sub-sectors include therapeutic development (oncology, immunology, rare diseases), diagnostics, gene editing (CRISPR), synthetic biology, agricultural biotechnology, and biomanufacturing. Many biotech startups originate from university research programs and maintain close ties to academic institutions.
Biotech companies have unique needs for specialized CROs (contract research organizations), lab equipment, regulatory consulting, IP legal services, and scientific talent. Reaching biotech founders after a funding round is particularly valuable, as these companies often immediately invest in expanding lab operations and clinical programs.